Min Wu
Molecular Biology · Signal Transduction and Targeted Therapy · 2020–2022
A researcher in the Science corpus: 5 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 175 citations into it
Whom Min Wu trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- Feng Zhang (in Molecular Biology)
Papers from Min Wu's perspective
Ordered by how strongly the researchers Min Wu trusts endorse each paper. Same corpus, a different order for every researcher.
- A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
- High frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
- DNA targeting specificity of RNA-guided Cas9 nucleases
- Cas9–crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria (Proceedings of the National Academy of Sciences of the United States of America)
- Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors (Science)
- High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity (Nature Biotechnology)
- A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity (Nucleic Acids Research)
- CRISPR-assisted editing of bacterial genomes (Nature Biotechnology)
- Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases (Nature Biotechnology)
- Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins (Genome Research)
Their papers
- Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 (2021) — 3,841 citations
- Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics (2022) — 1,232 citations
- mRNA-based therapeutics: powerful and versatile tools to combat diseases (2022) — 653 citations
- A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity (2020) — 724 citations
- Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects (2020) — 1,313 citations